| Patient | Sigmund Freud |
|---|---|
| Date of birth | 1952-05-06 |
| Identifiers | MRN HR-ET005-SYN; SSN (made up) 000-05-8403 |
| Document date | 2026-10-26 |
| Author | Anton Reinholt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Five-month review: abstinence, screening results, pain and weight. [S]
Mr. Freud returns about five months after intake and four weeks after his wellness visit. He has not smoked for fourteen weeks. He takes varenicline 1 mg twice daily and two or three lozenges a day, and the patch was stopped at the wellness visit as planned. He has no muscle aches on atorvastatin 20 mg. The Candida stomatitis has not returned since he began cleaning the obturator nightly and leaving it out at night. His low-dose CT of the chest two weeks ago showed a 4 mm nodule (Lung-RADS 2), mild emphysema and coronary artery calcification; the aortic ultrasound was normal. He has no cough or breathlessness. His pain is 2 of 10, and he has stopped the nutrition supplements because he eats well. [S]
| Element | Detail |
|---|---|
| Tobacco | No smoking for fourteen weeks; varenicline continues; two or three lozenges a day |
| Low-dose CT | Lung-RADS 2; mild emphysema; coronary calcification |
| Aortic ultrasound | 2.7 cm, normal |
| Atorvastatin | 20 mg daily for four weeks; no muscle aches |
| Pain | 2 of 10 |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight up; energy good |
| Ears, nose, mouth, and throat | Negative | No sore, lump, bleeding or nasal leakage |
| Respiratory | Negative | No cough, breathlessness or blood in sputum |
| Musculoskeletal | Negative | No muscle aches |
| Psychiatric | Negative | Mood steady; occasional brief cravings |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily for three days, then twice daily for four days, after food | Oral route | 2026-06-01 to 2026-06-08 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks | One tablet twice daily after food | Oral route | 2026-06-08 | active | S |
| Nicotine 21 mg/24 hours transdermal patch, one patch each morning from the quit date, for six weeks | One patch each morning | Topical route | 2026-07-20 to 2026-08-31 | completed | S |
| Nicotine 14 mg/24 hours transdermal patch, one patch each morning for four weeks, then stop | One patch each morning | Topical route | 2026-08-31 to 2026-09-28 | completed | S |
| Nicotine 4 mg oral lozenge, one lozenge as needed for cravings, up to 10 a day, dissolved on the side away from the obturator; gum avoided because it sticks to the prosthesis | One lozenge as needed, up to 10 a day | Oral route | 2026-07-20 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site | Two tablets three times daily | Oral route | 2026-06-01 | active | S |
| Nystatin 100,000 units/mL oral suspension, 5 mL swished around the mouth and defect for as long as possible and then swallowed, four times daily with the obturator out, for 14 days | 5 mL four times daily for 14 days | Oral route | 2026-09-14 to 2026-09-28 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-09-28 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-26 | Body height | 172 | cm | S |
| 2026-10-26 | Body weight | 60.6 | kg | S |
| 2026-10-26 | Body mass index (BMI) [Ratio] | 20.5 | kg/m2 | S |
| 2026-10-26 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-10-26 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-10-26 | Heart rate | 68 | /min | S |
| 2026-10-26 | Respiratory rate | 14 | /min | S |
| 2026-10-26 | Body temperature | 36.6 | Cel | S |
| 2026-10-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-26 | Hemoglobin [Mass/volume] in Blood | 13.8 | g/dL | 13.5-17.5 g/dL | Normal | S |
| 2026-10-26 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 92 | fL | 80-100 fL | Normal | S |
| 2026-10-26 | Albumin [Mass/volume] in Serum or Plasma | 3.9 | g/dL | 3.5-5 g/dL | Normal | S |
| 2026-10-26 | Creatinine [Mass/volume] in Serum or Plasma | 0.98 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-10-26 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 81 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-10-26 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 25 | U/L | 7-55 U/L | Normal | S |
| 2026-10-26 | Pain severity in the past week - 0-10 numeric rating [Reported] | 2 | {score} | S |
Vital signs recorded on 2026-10-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 130/78, pulse 68; weight 60.6 kg |
| Mouth | Mucosa healthy; no plaques, ulcer, mass or white or red patch; obturator clean and well fitting |
| Neck | No lymph nodes felt |
| Respiratory | Clear to auscultation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smoking | active | confirmed | F17.290 | S — Synthetic modern coding; person-first language; not a claim about his real diagnosis. |
| Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillance | active | confirmed | Z85.818 | S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic. |
| Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorly | active | confirmed | Z90.09 | S — Synthetic modern coding anchored to his documented obturator. |
| Hypernasal speech and nasal leakage of liquids from a poorly sealing obturator | resolved | confirmed | R49.21 | S — Synthetic finding; resolved when the new obturator was fitted. |
| Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubs | active | confirmed | G89.29 | S — Synthetic modern coding anchored to his documented constant mouth pain. |
| Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smoking | active | confirmed | E78.5 | S — Synthetic finding on the intake lipid panel. |
| Weight loss of 4 kg in six months from painful chewing and leakage, with a low albumin | resolved | confirmed | R63.4 | S — Synthetic finding; resolved as weight and albumin recovered. |
| Candida stomatitis of the palate and defect under the new obturator; treated with nystatin and prosthesis hygiene; resolved | resolved | confirmed | B37.0 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | No smoking for fourteen weeks; exhaled carbon monoxide 3 ppm (narrative) |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | 1 mg twice daily; no side effects; to complete 24 weeks next month |
| Medication safety | Combination nicotine replacement (patch and lozenge) | From the quit date for at least 8 to 12 weeks | Completed today | Patch finished after ten weeks; lozenges two or three a day, to taper |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Completed today | Quitline every two weeks; final call next month |
| Self-management | Relapse prevention | Every visit | Completed today | No slips since the second week |
| Laboratory | Kidney function for varenicline dosing | Baseline; again if illness or new medicines | Completed today | Creatinine 0.98 mg/dL, eGFR 81 |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Mouth and neck normal today; surgeon's next yearly examination next summer |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | No symptoms or signs |
| Imaging | Lung cancer screening eligibility | Yearly low-dose CT when chosen by shared decision | Completed today | Low-dose CT two weeks ago: Lung-RADS 2; next in 12 months |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | Obturator clean and well fitting; nightly cleaning and overnight removal continue |
| Examination | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Completed today | Therapy course finished; normal resonance |
| Self-management | Dental care (high-fluoride toothpaste, cleaning every three months) | Daily toothpaste; cleaning every three months | Completed today | Dental cleaning last month |
| Examination | Weight and nutrition | Every visit | Completed today | 60.6 kg; supplements stopped |
| Laboratory | Albumin | Baseline and at three months while weight is recovering | Completed today | Albumin 3.9 g/dL; hemoglobin 13.8 g/dL, MCV 92 fL |
| Laboratory | ALT and muscle symptoms on atorvastatin | Baseline, then if symptoms | Completed today | ALT 25 U/L; no muscle symptoms |
| Survey | Pain score and function | Every visit | Completed today | 2 of 10 |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day; may move to as needed |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed |
Goal progress:
Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Lung Cancer: Screening (2021)
Follow-up: Stop varenicline after 24 weeks next month. Review in three months with spirometry. Low-dose CT and the surgeon's examination yearly. Next wellness visit in one year. [S]